Ad
Tuesday, 13 June 2017
Pfizer, Roche and Aspen face South Africa probe over cancer drug prices
PRETORIA (Reuters) - South Africa's competition watchdog has launched an investigation into three pharmaceutical companies suspected of charging excessively for cancer medicines, the agency's head Tembinkosi Bonakele said on Tuesday.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment